Trial Clínico: Utilidad Del Telemonitoreo en Pacientes Con IC Como Medio de Apoyo Para la autogestión de la Enfermedad
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Heart Failure
- Sponsor
- Universidad Nacional de Tucuman
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- Changes in quality of life through the Minnesota Living with Heart Failure Questionnaire (MLHFQ)
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
This randomized controlled clinical trial compares a home telemonitoring system (HTS) versus usual care during a 90 days follow-up period of Heart Failure (HF) ambulatory patients, in order to evaluate if the use of the HTS improves quality of life and HF related-knowledge. The study was reviewed and approved by the Methodological Committee and by the Research Ethics Committee from the Provincial Health System, according to the Declaration of Helsinki. Written informed consent was obtained before randomization.
Investigators
Lucía María Yanicelli
Principal Investigator PhD in Exact Sciences and Engineering
Universidad Nacional de Tucuman
Eligibility Criteria
Inclusion Criteria
- •were over 18 years with a primary diagnosis of HF,
- •had been hospitalized at least once time as a consequence of a HF decompensation,
- •had a Smartphone,
- •had access to WiFi,
- •had access to a weight scale and to a blood-pressure monitor
Exclusion Criteria
- •illiterate patients,
- •had learning difficulties,
- •had a cognitive impairment sufficient to interfere with the use of the telemonitoring system, or had a severe depression that could interfere with their quality of life perception.
Outcomes
Primary Outcomes
Changes in quality of life through the Minnesota Living with Heart Failure Questionnaire (MLHFQ)
Time Frame: 3-month
Changes in HF related knowledge through the Knowledge of CHF questionnaire
Time Frame: 3-month